Cantel Medical Corp (CMD.N)
CMD.N on New York Stock Exchange
89.20USD
16 Aug 2019
89.20USD
16 Aug 2019
Change (% chg)
$0.48 (+0.54%)
$0.48 (+0.54%)
Prev Close
$88.72
$88.72
Open
$89.00
$89.00
Day's High
$90.02
$90.02
Day's Low
$89.00
$89.00
Volume
36,310
36,310
Avg. Vol
68,620
68,620
52-wk High
$99.67
$99.67
52-wk Low
$63.52
$63.52
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Apr '19 | 228.55 | 0.197 |
| Jan '19 | 224.54 | 0.451 | |
| Oct | 225.59 | 0.482 | |
| FY 2018 | Jul '18 | 228.85 | 0.411 |
| Apr '18 | 217.27 | 0.435 | |
| Jan '18 | 213.03 | 0.576 | |
| Oct | 212.77 | 0.548 | |
| FY 2017 | Jul '17 | 205.50 | 0.407 |
| Apr '17 | 192.11 | 0.419 | |
| Jan '17 | 184.82 | 0.432 | |
| Oct | 187.73 | 0.450 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Apr-19 | 4 | 227.55 | 229.60 | 225.60 | -- |
| Quarter Ending Jul-19 | 4 | 238.07 | 240.50 | 236.70 | 252.29 |
| Year Ending Jul-19 | 5 | 917.41 | 920.00 | 915.30 | 967.26 |
| Year Ending Jul-20 | 4 | 990.70 | 1,017.00 | 975.40 | 1,060.56 |
| Earnings (per share) | |||||
| Quarter Ending Apr-19 | 3 | 0.56 | 0.58 | 0.54 | -- |
| Quarter Ending Jul-19 | 3 | 0.61 | 0.61 | 0.60 | 0.77 |
| Year Ending Jul-19 | 4 | 2.35 | 2.36 | 2.34 | 2.90 |
| Year Ending Jul-20 | 4 | 2.65 | 2.74 | 2.59 | 3.27 |
| LT Growth Rate (%) | 1 | 2.75 | 2.75 | 2.75 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 56.96 | 31.72 | 32.67 | |
| P/E High - Last 5 Yrs. | 47.58 | 39.41 | 47.29 | |
| P/E Low - Last 5 Yrs. | 27.86 | 19.01 | 23.87 | |
| Beta | 1.22 | 0.80 | 0.89 | |
| Price to Sales (TTM) | 5.27 | 6.55 | 7.91 | |
| Price to Book (MRQ) | 7.75 | 4.97 | 5.38 | |
| Price to Tangible Book (MRQ) | 46.14 | 15.86 | 6.71 | |
| Price to Cash Flow (TTM) | 38.72 | 21.52 | 24.37 | |
| % Owned Institutions | 86.64 | 4.39 | 1.45 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 0.14 | 1.07 | 1.35 | |
| Dividend Yield - 5 Year Avg | 0.21 | 1.30 | 1.38 | |
| Dividend 5 Year Growth Rate | 15.07 | 15.42 | 4.54 | |
| Payout Ratio(TTM) | 0.00 | 31.06 | 40.24 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 14.80 | 8.74 | 12.23 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 15.86 | 2.10 | 7.74 | |
| Sales - 5 Yr. Growth Rate | 14.79 | 8.44 | 10.88 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 4.19 | 58.56 | 42.99 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 18.87 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 17.32 | 19.46 | 10.32 | |
| Capital Spending - 5 Yr. Growth Rate | 37.52 | 7.09 | 14.84 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.49 | 2.50 | 2.21 |
| Current Ratio (MRQ) | 2.41 | 3.22 | 3.03 |
| LT Debt to Equity (MRQ) | 24.05 | 27.58 | 10.20 |
| Total Debt to Equity (MRQ) | 24.05 | 34.65 | 14.55 |
| Interest Coverage (TTM) | 31.31 | 15.74 | 29.80 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 47.72 | 60.24 | 52.25 | |
| Gross Margin - 5 Yr. Avg. | 45.67 | 59.58 | 50.41 | |
| EBITD Margin (TTM) | 19.80 | -- | -- | |
| EBITD - 5 Yr. Avg | 19.23 | 23.20 | 13.13 | |
| Operating Margin (TTM) | 14.34 | 17.99 | 6.92 | |
| Operating Margin - 5 Yr. Avg. | 14.43 | 16.19 | 8.94 | |
| Pre-Tax Margin (TTM) | 13.79 | 17.85 | 6.13 | |
| Pre-Tax Margin - 5 Yr. Avg. | 13.91 | 16.52 | 9.23 | |
| Net Profit Margin (TTM) | 9.27 | 13.67 | 2.76 | |
| Net Profit Margin - 5 Yr. Avg. | 8.98 | 11.65 | 5.60 | |
| Effective Tax Rate (TTM) | 32.81 | 23.07 | 22.40 | |
| Effective Tax Rate - 5 Yr. Avg. | 35.41 | 28.49 | 22.74 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 329,549 | 27,860,118 | 887,145,970 | |
| Net Income/Employee (TTM) | 30,543 | 3,155,375 | 101,828,577 | |
| Receivable Turnover (TTM) | 7.55 | 5.09 | 5.93 | |
| Inventory Turnover (TTM) | 4.23 | 3.19 | 3.36 | |
| Asset Turnover (TTM) | 1.04 | 0.79 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 9.64 | 10.76 | 11.17 | |
| Return on Assets - 5 Yr. Avg. | 8.99 | 9.19 | 12.34 | |
| Return on Investment (TTM) | 11.17 | 14.11 | 14.48 | |
| Return on Investment - 5 Yr. Avg. | 10.31 | 11.84 | 16.02 | |
| Return on Equity (TTM) | 14.50 | 16.67 | 15.78 | |
| Return on Equity - 5 Yr. Avg. | 13.31 | 14.09 | 17.01 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 15.86 | 16.37 | 14.79 |
| EPS (TTM) % | 18.87 | 17.85 | 17.32 |
| Dividend % | -18.75 | 16.60 | 15.07 |
Note: Units in Millions of US Dollars
Performance for Cantel Medical Corp
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 18.42 | 14.33 | 99 | 50 |
| 13 Week | 29.19 | 22.90 | 99 | 74 |
| 26 Week | 31.51 | 21.52 | 99 | 63 |
| 52 Week | 23.17 | 4.40 | 99 | 47 |
| YTD | 23.53 | 8.48 | 99 | 44 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 95.21% |
| # of Holders: | 326 |
| Total Shares Held: | 39,765,930 |
| 3 Mo. Net Change: | 2,174,078 |
| # New Positions: | 34 |
| # Closed Positions: | 43 |
| # Increased Positions: | 140 |
| # Reduced Positions: | 151 |
| # Net Buyers: | -11 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.